Related Experiment Video
Updated: Jan 5, 2026

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
A modern approach to the treatment of plaque psoriasis
Daniela Ledić Drvar1, Tomislav Vlahinić2, Željan Maleš3
1Department of Dermatology and Venereology, University Hospital Centre Zagreb, School of Medicine, University of Zagreb, HR-10000Zagreb, Croatia.
Insights
Psoriasis is a chronic inflammatory skin condition affecting 1.6% of the Croatian population. Its development involves genetics, immune issues, and environmental factors, with targeted therapies advancing personalized medicine.
Area of Science:
- Dermatology
- Immunology
- Genetics
Background:
- Psoriasis is a prevalent chronic inflammatory skin disease affecting 0.5-3% globally and 1.6% in Croatia.
- Disease prevalence shows a bimodal distribution with peaks in young adulthood (20-30) and later adulthood (50-60).
- Multifactorial etiopathogenesis involves genetic predisposition, immune dysregulation, environmental triggers, and compromised skin barrier function.
Purpose of the Study:
- To review the epidemiology, etiopathogenesis, clinical variants, and treatment strategies for psoriasis.
- To highlight the role of key signaling pathways such as TNF-α, IL-23, and IL-17.
- To discuss the evolution towards personalized medicine in psoriasis management.
Main Methods:
- Literature review of epidemiological data, etiological factors, and therapeutic approaches.
- Analysis of key molecular pathways implicated in psoriasis pathogenesis.
- Examination of current and emerging treatment modalities.
Main Results:
- Psoriasis affects diverse age groups with distinct epidemiological patterns.
- Genetic and immunological factors, alongside environmental influences, are central to disease development.
- Targeted therapies are crucial for moderate-to-severe cases unresponsive to conventional treatments.
Conclusions:
- Understanding psoriasis's complex etiology is key to effective management.
- Advancements in immunogenetics are driving the development of personalized treatment strategies.
- The future of psoriasis care lies in tailored, targeted therapeutic interventions.
Abstract:
Psoriasis is a common chronic inflammatory skin disease which affects 0.5-1 % of children and 2-3 % of the adult population. In Croatia, 1.6 % of the population suffer from psoriasis. Distribution of the disease is bimodal, with the first peak at the age of 20-30, and the second at the age of 50-60. The etiopathogenesis of the disease is multifactorial, the key factors being genetic predisposition combined with immunological disorders, environmental factors and skin barrier damage. There are several clinical variants of the disease. The main signalling pathways in psoriasis include TNF-α, IL-23 and IL-17. Topical agents are used for the treatment of the mild form, and the systemic conventional therapy is used for the treatment of moderate to severe forms of the disease. In cases where's no response, or intolerance or contraindications are present, new targeted medications are to be administered. Development in the field of immunogenetics of psoriasis leads to personalized medicine.
More Related Videos
Related Concept Videos
Treatment Strategies for Psychological Disorders
Psychological therapies focus on modifying emotions, thoughts, and behaviors through talking, interpreting, listening, rewarding, challenging, and modeling. Clinical psychologists, counselors, and social workers commonly practice psychotherapy. Clinical...
Drug Therapy
Antianxiety Medications
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Atherosclerosis III: Management
Psychosis: Goals of Pharmacotherapy
Peripheral Artery Disease III: Interprofessional Care

